Saudi Arabia approves entry of tourists jabbed with Sputnik

Saudi Arabia approves entry of tourists jabbed with Sputnik
Saudi Arabia will allow those vaccinated with Russia's Sputnik jab to enter the country in a move that will enable Muslims to take part in religious pilgrimages, the vaccine's developers announced
2 min read
05 December, 2021
Saudi Arabia will allow tourists with the Sputnik vaccine [Getty]

Saudi Arabia has granted approval for people vaccinated with Russia's Sputnik jab to enter the country in a move that will enable Muslims to take part in religious pilgrimages, the vaccine's developers said Sunday.

"The Kingdom of Saudi Arabia has granted approval for entry of individuals vaccinated with the Russian Sputnik V vaccine starting from January 1, 2022," the Russian Direct Investment Fund (RDIF), which financed the development of Sputnik V, said in a statement.

The decision, said the fund, "will enable Muslims from all over the world vaccinated with Sputnik V to participate in the Hajj and the Umrah pilgrimages to Islam's holiest sites in the cities of Mecca and Medina."

Foreign tourists vaccinated with Sputnik will still be required to quarantine for 48 hours and take a PCR test.

Saudi Arabia has joined more than 100 countries accepting visitors vaccinated with Sputnik, the RDIF said, adding that only 15 countries including the United States currently require travellers to be jabbed with vaccines other than Sputnik.

The hajj -- a must for able-bodied Muslims at least once in their lives -- typically packs millions of pilgrims into congested religious sites and could be a major source of contagion during the pandemic.

MENA
Live Story

The coronavirus outbreak has for a second year forced Saudi authorities to dramatically downsize the hajj, and just 60,000 fully vaccinated citizens and residents of the kingdom have taken part this year.

The coronavirus has killed more than five million people since emerging in China in December 2019.

Russia registered Sputnik V in August 2020 ahead of large-scale clinical trials, prompting concern among experts over the fast-tracked process.

But it was since declared safe and more than 90 percent effective in a report published by leading medical journal The Lancet.

But the Russian vaccine has not so far been approved by the World Health Organization or by the medical authorities of the European Union and the United States.